Stephanie A. Sweetana

Author

Also Known As

S Sweetana, S. A. Sweetana, S.A. Sweetana, Stephanie A Sweetana, Stephanie A. Sweetana, Stephanie Sweetana, Sweetana, S.A.

Publications

763

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Jubilant Life Sciences (India)Institute of Organic Chemistry

About

Stephanie A. Sweetana is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	318
2	Biochemistry	4	4	137
3	Natural Sciences	2	2	69
4	Diabetes	2	2	88
5	Public Health	1	1	22

Stephanie A. Sweetana

Publications

637

Citations

H-Index

Page 1

	Year	Citations
In Vitro Measurement of Gastrointestinal Tissue Permeability Using a New Diffusion Cell George M. Grass, Stephanie A. Sweetana Pharmaceutical Research	1988	247
Solubility principles and practices for parenteral drug dosage form development. Stephanie A. Sweetana, Michael J. Akers PubMed Pharmaceutical SciencePharmacotherapyDrug DispensingSolution (Chemistry)Pharmaceutical Formulation	1997	118
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470) Chafiq Hamdouchi, Steven D. Kahl, Anjana Patel Lewis, Journal of Medicinal Chemistry PharmacotherapyInsulin SignalingTranslational PharmacologyMetabolic SyndromeMolecular Pharmacology	2016	58
Regional‐Dependent Intestinal Absorption and Meal Composition Effects on Systemic Availability of LY303366, a Lipopeptide Antifungal Agent, in Dogs Cheng Li, David Fleisher, Lü Li, Journal of Pharmaceutical Sciences NutritionAnimal NutritionMedicineGastroenterologyRegional‐dependent Intestinal Absorption	2001	41
2-Chloro-4-[[(1<i>R</i>,2<i>R</i>)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy Ashraf Saeed, Grant M. Vaught, Kostas Gavardinas, Journal of Medicinal Chemistry Compound 6PharmacotherapyDermatologyMuscle AtrophyMolecular Pharmacology	2015	39
A Correlation of Permeabilities for Passively Transported Compounds in Monkey and Rabbit Jejunum George M. Grass, Stephanie A. Sweetana Pharmaceutical Research	1989	30
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus Chafiq Hamdouchi, Pranab Maiti, Alan M. Warshawsky, Journal of Medicinal Chemistry Fused HeterocyclesPharmacotherapyMedicinal ChemistryPotent Gpr40Insulin Delivery	2017	30
Design, synthesis and structure–activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors Maria-Carmen Fernandez, Ana Escribano, Ana Mateo, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryOrganic ChemistryPharmacologyCetp InhibitorsPharmaceutical Chemistry	2012	28
Development of a selective androgen receptor modulator for transdermal use in hypogonadal patients Venkatesh Krishnan, Nita Patel, James G. MacKrell, Andrology Hormonal ContraceptiveFertilitySkin Absorption PropertiesReproductive HealthGynecology	2018	22
Application of oral bioavailability surrogates in the design of orally active inhibitors of rhinovirus replication Robert E. Stratford, Michael P. Clay, Beverly A. Heinz, Journal of Pharmaceutical Sciences	1999	14

Page 1